Effect of Evolocumab in Functional Status and LDL Oxidation of Patients With Peripheral Arterial Disease
Clinical trial NCT04306081 · UNKNOWN
Trial details
- NCT number
- NCT04306081
- Sponsor
- Leonardo Clavijo
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-14
- Primary completion
- 2020-12-30
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.